Driving reinvestment in R&D for antibiotics and advocating their responsible use

17th International Congress on Infectious Diseases (ICID)

The 17th International Congress on Infectious Diseases (ICID) is taking place in Hyderabad, India, from March 2-5, 2016. This year DRIVE-AB will be collaborating on a symposium titled, “New and recently approved antibiotics: Challenges and opportunities”. The symposium will take place on Saturday, March 5 in Hall 2 from 10:15 – 12:15hrs and will be co-chaired by R. Rangarajan (India) and DRIVE-AB participant U. Theuretzbacher (Austria).

Another DRIVE-AB participant, C. Årdal (Norway), will be giving a presentation during the symposium  on “Incentivising antibiotic innovation“.

New and Recently Approved Antibiotics: Challenges and Opportunities

(in collaboration with DRIVE-AB- a project of the Innovative Medicines Initiative)
Saturday, March 5, 2016, 10:15 – 12:15hrs, Room: Hall 2
Co-chairs: R. Rangarajan (India), U. Theuretzbacher (Austria)

New Antibiotics: What do we Need?
D. Morgan (USA)

The Antibiotic Pipeline: What Can we Expect?
U. Theuretzbacher (Austria)

Incentivizing Antibiotic Innovation
C. Årdal (Norway)

Sustaining the Clinical Use of Antibiotics
A. Holmes (United Kingdom)

Please click here to view the entire 17th ICID program.

Please click here to view the presentation, “The Antibiotic Pipeline: What Can We Expect?”.

Please click here to view the presentation, “Incentivizing Antibiotic Innovation”.


Back to External Events